๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hemolytic anemia following intravenous immunoglobulin administration

โœ Scribed by Fang Yin; John A. Nesbitt; Aaron A.R. Tobian; Peter A. Holt; Jamal Mikdashi

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
196 KB
Volume
83
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hemolytic anemia associated with intrave
Hemolytic anemia associated with intravenous immunoglobulin
โœ John R. Wilson; Nirmala Bhoopalam; Morris Fisher ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB ๐Ÿ‘ 2 views

Intravenous immunoglobulin (IVIg) is a useful tool in the treatment of a variety of neuromuscular disorders. Though IVIg therapy is generally safe, hemolytic anemia is a potentially serious complication that is often overlooked, and is currently not listed in product inserts. We analyzed 45 patients

Diphenhydramine kinetics following intra
Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration
โœ Joseph M. Scavone; Becki G. Luna; Jerold S. Harmatz; Lisa von Moltke; David J. G ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 272 KB

Eight healthy volunteers received 50 mg of dimenhydrinate, a theoclate salt of diphenhydramine, orally, sublingually, and intravenously on three separate occasions in random sequence. Plasma diphenhydramine concentrations during 12 h after each dose were measured by gas-liquid chromatography with ni